Invesco’s OPTIMER PHARMACEUTICALS, INC. COM STK OPTR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2013
Q4
Sell
-768
Closed -$10K 4451
2013
Q3
$10K Hold
768
﹤0.01% 4223
2013
Q2
$11K Buy
+768
New +$11.2K ﹤0.01% 4179

Invesco's OPTR Position: Q4 2013 in Review

Invesco sold out of OPTIMER PHARMACEUTICALS, INC. COM STK (OPTR) in Q4 2013, closing a stake of 768 shares — an estimated $10K sold.

Invesco first reported a position in OPTR in Q2 2013 and held it in 2 quarters. The position peaked at $11K in Q2 2013. 0 funds tracked by Wall St. Rank hold OPTR as of Q4 2013.

  • Invesco reported no remaining OPTIMER PHARMACEUTICALS, INC. COM STK position as of Q4 2013 after selling out during the quarter.
  • Invesco sold 768 OPTIMER PHARMACEUTICALS, INC. COM STK shares in Q4 2013, an estimated $10K.
  • Invesco first reported a position in OPTIMER PHARMACEUTICALS, INC. COM STK in Q2 2013 and held it in 2 quarters.
  • Invesco's OPTIMER PHARMACEUTICALS, INC. COM STK position peaked at $11K in Q2 2013.
  • 0 funds tracked by Wall St. Rank held OPTIMER PHARMACEUTICALS, INC. COM STK as of Q4 2013.

Based on Invesco's 13F filing for Q4 2013, filed 13 Feb 2014.